Pharmacist Issued Warning After Unauthorised Access to Patient Records via Shared Prescriber Login
Date of Decision: April 30, 2026
Registrant's Role: Pharmacist
Allegations:
- Asked a prescriber (Dr A) via WhatsApp for login details to the Roseway Labs (eRoseway) prescribing portal.
- Personally used and/or failed to prevent others from using Dr A’s login to access confidential patient information.
- Knew or ought to have known that he did not have permission to possess or use the login or access patient data.
- Acted without integrity by engaging in the above conduct.
Outcome: Warning issued
GPhC Standards Breached:
- Standard 6 – Behave in a professional manner at all times
- Standard 7 – Respect and maintain a person’s confidentiality and privacy
- Standard 8 – Speak up when you have concerns or when things go wrong
- Standard 9 – Demonstrate leadership
Case Summary
Allegations
This case concerns a superintendent pharmacist who accessed confidential patient information through an online prescribing platform (eRoseway) using login credentials that were not assigned to him.
The registrant worked at a private compounding pharmacy producing hormone medications, where prescribing workflows often involved digital platforms. The system in question, operated by Roseway Labs, allowed prescribers such as Dr A to log in and manage patient prescriptions.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
View the Full Determination Document
The original determination transcript is available to registered users.
- Download the official GPhC determination
- Full hearing transcript
- Detailed findings of fact
- Sanction reasoning
- Details of the pharmacy professionals involved